TABLE 1

Patient Characteristics

Characteristic18F-DCFPyL18F-PSMA-1007
All patients
 n120120
 PSA (μg/mL)11.6 (0.1–558)12.0 (0.1–577)
Primary staging
n6969
 PSA (μg/mL)14.8 (3.2–558)14.7 (2.4–577)
Gleason score*
 ≤7a178
 ≥7b5158
 Unknown14
T stage
 T12315
 T22527
 T31622
 T404
 Unknown51
Androgen deprivation therapy00
Biochemical recurrence
 n2121
 PSA (μg/mL)2.4 (0.4–7.9)2.4 (0.4–7.8)
Previous therapy
 Prostatectomy77
 Radiation therapy1212
 Brachytherapy22
 Androgen deprivation therapy12
Follow-up systemic treatment
n3030
 PSA (μg/mL)24.8 (0.1–385.0)26.3 (0.1–369.0)
 Androgen deprivation therapy3030
  • * P = 0.402 (Mann–Whitney U test),

  • P = 0.009 (Mann–Whitney U test).

  • Only temporarily after radiation therapy with curative intent.

  • Qualitative data are number; continuous data are median followed by range in parentheses.